Bicara Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -54,712 | -56,115 | -37,322 | -36,234 |
EBIT | -55,375 | -56,159 | -37,333 | -36,290 |
Net Income | -55,436 | -56,211 | -37,386 | -36,330 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -44,266 | -37,568 | -24,124 | -29,290 |
Cash | 96,599 | 323,462 | 96,685 | 171,673 |
Basic Shares | 67,925 | 60,717 | 55,142 | 54,563 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -56 | -19 | -10 | |
EBITDA | -137,628 | -67,752 | -51,961 | -37,722 |
EBIT | -137,733 | -67,808 | -51,980 | -37,732 |
Net Income | -137,950 | -67,995 | -51,985 | -37,845 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -107,114 | -74,822 | -46,214 | -32,268 |
Cash | 96,685 | 489,711 | 230,440 | 4,158 |
Basic Shares | 54,676 | 54,424 | 51,760 | 51,760 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.82 |
2026-03-31 | -$0.93 |
2025-12-31 | -$0.68 |
2025-09-30 | -$0.67 |